Anúncio
Anúncio
ADMA
ADMA Biologics, Inc.
17.88
USDPatrocinado
-0.36
-1.96%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
17.98
+0.09
+0.51%
Relatórios de Lucros ADMA
Rácio de surpresa positiva
ADMA separação 18 de 40 últimas estimativas.
45%
Próximo Relatório
Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$142.44M
/$0.18
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+6.12%
/+20.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+21.18%
/+28.57%
ADMA Biologics, Inc. earnings per share and revenue
On 05 de nov. de 2025, ADMA reported earnings of 0.15 USD per share (EPS) for Q3 25, missing the estimate of 0.15 USD, resulting in a -1.96% surprise. Revenue reached 134.22 milhão, compared to an expected 133.14 milhão, with a 0.81% difference. The market reacted with a -8.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of 0.18 USD, with revenue projected to reach 142.44 milhão USD, implying an aumentar of 20.00% EPS, and aumentar of 6.12% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were ADMA Biologics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, ADMA Biologics, Inc. reported EPS of $0.15, missing estimates by -1.96%, and revenue of $134.22M, 0.81% above expectations.
How did the market react to ADMA Biologics, Inc.'s Q3 2025 earnings?
The stock price moved down -8.72%, changed from $15.37 before the earnings release to $14.03 the day after.
When is ADMA Biologics, Inc. expected to report next?
The next earning report is scheduled for 02 de mar. de 2026.
What are the forecasts for ADMA Biologics, Inc.'s next earnings report?
Based on 4
analistas, ADMA Biologics, Inc. is expected to report EPS of $0.18 and revenue of $142.44M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio